Panchsheel Organics informs on demise of promoter MD Mahendra Turakhia

Panchsheel Organics has informed the Bombay Stock Exchange (BSE) of the demise of its Executive Whole Time Director and promoter, Mr. Mahendra Abhaychand Turakhia, on August 01, 2026. The disclosure, made under Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, highlights a significant leadership transition for the bulk drug manufacturer, as Mr. Turakhia was also the company’s Managing Director and held a substantial 16.10% stake.

The company submitted the intimation to the BSE on August 03, 2026, citing the sad demise of Mr. Turakhia, who held DIN 00006222. In its communication, Panchsheel Organics expressed that his unexpected passing is an irreparable loss to the organization. The Board of Directors and employees have extended their deep sympathy and condolences to his family. The filing references Master Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, regarding disclosures related to changes in key managerial personnel.

Shareholding Details

Mr. Turakhia’s exit from the board due to death leaves a notable gap in the promoter group’s direct holding. As per the annexure filed with the exchange, he held 21,20,672 shares at the time of his demise.

Particulars	Information
Name	Mr. Mahendra Abhaychand Turakhia
Reason for Change	Death
Date of Cessation	August 01, 2026
Category	Executive Whole Time Director, Promoter, Managing Director
Number of Shares	21,20,672
Percentage Holding	16.10%

Leadership Implications

The departure of a promoter and Managing Director simultaneously impacts both the strategic direction and operational oversight of Panchsheel Organics. With Mr. Turakhia holding over 16% of the equity, his estate will likely retain significant influence in future shareholder decisions, though immediate governance adjustments will be required to fill the executive vacuum. The company has not yet disclosed plans for interim leadership or the appointment of a successor in this filing.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-4.64%	-5.04%	-5.08%	+6.51%	-37.43%	+133.33%

Panchsheel Organics Limited has published the extract of its audited financial results for the quarter and year ended March 31, 2026, in newspapers on June 1, 2026. The results were previously approved by the Board of Directors during its meeting held on May 30, 2026. The company operates in a single reportable segment, the manufacturing and trading of bulk drugs and intermediates, with total assets reported at ₹17,193.14 lakh as of March 31, 2026.

For the financial year ended March 31, 2026, the company reported a net profit of ₹1,083.04 lakh, a decrease from ₹1,379.45 lakh in the previous year. Revenue from operations for FY26 stood at ₹10,678.26 lakh, compared to ₹10,717.8 lakh in FY25. The board recommended a final dividend of ₹0.80 per share for the financial year, subject to shareholder approval at the ensuing Annual General Meeting. The record date for determining eligibility has been fixed as Friday, June 12, 2026.

Key Financial Metrics for FY26

Metric	FY26 (₹ in Lakhs)	FY25 (₹ in Lakhs)
Revenue from Operations	10,678.26	10,717.80
Total Income	11,030.25	11,025.13
Total Expenses	9,583.56	9,215.43
Net Profit for the Period	1,083.04	1,379.45
Earnings Per Share (Basic)	8.22	10.47

For the quarter ended March 31, 2026, the company recorded a net profit of ₹170.22 lakh, compared to ₹317.11 lakh in the corresponding period of the previous year. Revenue from operations for Q4FY26 was ₹3,107.14 lakh. M/s. Jayesh R. Shah & Co., Chartered Accountants, the statutory auditors, issued an unmodified opinion on the financial results.

The board approved related party transactions for the year 2026-27 through omnibus approval and appointed M/s. Talati and Associates as the cost auditor for the financial year 2026-27. The trading window for designated persons remains closed until 48 hours after the declaration of the audited financial results.